{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:50:25Z","timestamp":1761155425397},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We analysed specific IgG subclasses levels to Mycobacterium leprae sonicate extract (MSE), lipoarabinomannan B (LAM) and phenolic glycolipid I (PGL-I) in the sera of leprosy patients with different clinical manifestations. IgG2 was found to be the predominant antibody to MSE regardless of clinical manifestations, and IgG 1 response was mostly seen in lepromatous patients. IgG3 reacted only rarely but IgG4 reacted relatively more in certain clinical groups such as borderline lepromatous and lepromatous with erythema nodosum leprosum (ENL) reaction. Most of the IgG subclass responses to MSE could be accounted for reactivity with LAM, suggesting that LAM is the major immunogen involved in the pathogenesis of leprosy. In contrast to LAM. PGL-I antigen showed considerably lower reactivities for IgG subclasses. An association between IgG subclass responses and clinical manifestations of leprosy was also seen. Whereas borderline lepromatous patients were found to have significantly higher levels of IgG2 and lgG4 to MSE, lepromatous patients had elevated levels of IgG I and lower levels of IgG2. An interesting observation, however, was the significantly higher levels of IgG2 to LAM in the pure neuritic leprosy patients.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb03069.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T22:34:48Z","timestamp":1280183688000},"page":"253-257","source":"Crossref","is-referenced-by-count":14,"title":["Specificity of IgG subclass antibodies in different clinical manifestations of leprosy"],"prefix":"10.1093","volume":"88","author":[{"given":"S","family":"DHANDAYUTHAPANI","sequence":"first","affiliation":[{"name":"Central Leprosy Teaching and Research Institute, Chengulpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"IZUMI","sequence":"additional","affiliation":[{"name":"National Institute for Leprosy Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"ANANDAN","sequence":"additional","affiliation":[{"name":"Central Leprosy Teaching and Research Institute, Chengulpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V N","family":"BHATIA","sequence":"additional","affiliation":[{"name":"Central Leprosy Teaching and Research Institute, Chengulpattu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011703313457700_b1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1984.tb00493.x","article-title":"Immunological unresponsiveness in leprosy","volume":"80","author":"Bloom","year":"1984","journal-title":"Immunol Rev"},{"key":"2022011703313457700_b2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/CMR.1.3.330","article-title":"Leprosy","volume":"1","author":"Hastings","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"2022011703313457700_b3","first-page":"144","article-title":"Leprosy IV. The quantitation of immune globulins (IgG, IgA and IgM) in leprosy sera","volume":"36","author":"Lim","year":"1968","journal-title":"Int J Lepr"},{"key":"2022011703313457700_b4","first-page":"863","article-title":"Studies of immune mechanisms in leprosy. II. Quantitative relationship of IgG. IgA and IgM immunoglobulins","volume":"75","author":"Bullock","year":"1970","journal-title":"J Lab Clin Med"},{"key":"2022011703313457700_b5","first-page":"212","article-title":"Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins. complements and c-reactive protein in sera of leprosy patients and healthy controls","volume":"26","author":"Srivastava","year":"1975","journal-title":"Tropenmed Parasitol"},{"key":"2022011703313457700_b6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3181\/00379727-140-36612","article-title":"Serum immunoglobulins in leprosy patients with different spectra of clinical manifestations","volume":"140","author":"Sirisinha","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"key":"2022011703313457700_b7","first-page":"43","article-title":"Immunological assessment of sera of leprosy patients","volume":"51","author":"Sengupta","year":"1979","journal-title":"Lcpr India"},{"key":"2022011703313457700_b8","first-page":"454","article-title":"Serum immunoglobulin profile and C3 level in lepromatous leprosy patients","volume":"54","author":"Harikrishnan","year":"1982","journal-title":"Lepr India"},{"key":"2022011703313457700_b9","first-page":"178","article-title":"Patterns of immunoglobulins in the serum of leprosy patients","volume":"59","author":"Choudhary","year":"1987","journal-title":"Ind J Lepr"},{"key":"2022011703313457700_b10","first-page":"225","article-title":"Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for serodiagnosis of leprosy","volume":"47","author":"Melsom","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/iai.36.3.885-892.1982","article-title":"Humoral Immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns","volume":"36","author":"Touw","year":"1982","journal-title":"Infect Immun"},{"key":"2022011703313457700_b12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.1990.tb05339.x","article-title":"Selective IgG subclass deficiency: quantification and clinical relevance","volume":"81","author":"Jefferis","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b13","first-page":"134","article-title":"IgG subclasses in viral infections","volume":"19","author":"Skvaril","year":"1986","journal-title":"Monogr Allergy"},{"key":"2022011703313457700_b14","first-page":"122","article-title":"IgG subclasses in bacterial infections","volume":"19","author":"Hammarstrom","year":"1986","journal-title":"Monogr Allergy"},{"key":"2022011703313457700_b15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/iai.42.1.237-244.1983","article-title":"Virus specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections","volume":"42","author":"Linde","year":"1983","journal-title":"Infect Immun"},{"key":"2022011703313457700_b16","first-page":"343","article-title":"IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages","volume":"73","author":"Ljunggren","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b17","first-page":"216","article-title":"Fine specificity of IgG subclass response to group antigens in HIV-1 infected patients","volume":"76","author":"Broliden","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b18","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.134.4.2707","article-title":"Prominence of lgG4 in the IgG antibody response to human filariasis","volume":"134","author":"Ottesen","year":"1985","journal-title":"J Immunol"},{"key":"2022011703313457700_b19","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.139.8.2794","article-title":"IgG antibody subclasses in human filariasis. Differential subclass recognition of parasitic antigens correlates with different clinical manifestations of infection","volume":"139","author":"Hussain","year":"1987","journal-title":"J Immunol"},{"key":"2022011703313457700_b20","first-page":"223","article-title":"Unique recognition of a low molecular weight Onchocerca volvulus antigen by IgG3 antibodies in chronic hyper-reactive oncho-dermatitis (Sowda)","volume":"74","author":"Cabrera","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b21","first-page":"230","article-title":"The sequential appearance of IgG subclasses and IgE during the course of Trichinella spiralis infection","volume":"74","author":"Ljungstrom","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2249.1990.tb06443.x","article-title":"Early antibody responses in human schistosomiasis","volume":"80","author":"Evengard","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011703313457700_b23","first-page":"255","article-title":"Classification of leprosy according to immunity. A five group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr"},{"key":"2022011703313457700_b24","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1128\/jcm.26.12.2474-2479.1988","article-title":"Recognition of mycobacterial antigens by sera from patients with leprosy","volume":"26","author":"Vega-Lopez","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2022011703313457700_b25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1146\/annurev.mi.41.100187.003241","article-title":"Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease","volume":"41","author":"Gaylord","year":"1987","journal-title":"Annu Rev Microbiol"},{"key":"2022011703313457700_b26","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1128\/iai.55.11.2860-2863.1987","article-title":"Most Mycobacterium leprae carbohydrate reactive monoclonal antibodies are directed primarily to lipoarabinomannan","volume":"55","author":"Gaylord","year":"1987","journal-title":"Infect Immun"},{"key":"2022011703313457700_b27","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.138.9.3028","article-title":"Mycobacterium leprae antigen induced suppression of T cell proliferation in vitro","volume":"138","author":"Kaplan","year":"1987","journal-title":"J Immunol"},{"key":"2022011703313457700_b28","first-page":"206","article-title":"The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharidcs upon polyclonal and monoclonal human T cell proliferation","volume":"74","author":"Moreno","year":"1988","journal-title":"Clin Fxp Immunol"},{"key":"2022011703313457700_b29","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/iai.56.5.1232-1236.1988","article-title":"Mycobacterial lipoarabinomannan inhibits gamma interferon mediated activation of macrophages","volume":"56","author":"Sibley","year":"1988","journal-title":"Infect Immun"},{"key":"2022011703313457700_b30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1523-1747.ep12354963","article-title":"IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum and bacillary persistence","volume":"86","author":"Levis","year":"1986","journal-title":"J Invest Dermatol"},{"key":"2022011703313457700_b31","first-page":"211","article-title":"Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients","volume":"53","author":"Andreoli","year":"1985","journal-title":"Int J Lepr"},{"key":"2022011703313457700_b32","first-page":"385","article-title":"A clinical, immunological and histological study of neuritic leprosy patients","volume":"59","author":"Kaur","year":"1991","journal-title":"Int J Lepr"},{"key":"2022011703313457700_b33","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.142.12.4422","article-title":"Functional role of human IgG subclasses in eosinophiL mediated killing of schistosomula of Schistosoma mansoni","volume":"142","author":"Khalife","year":"1989","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb03069.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/253\/42213176\/j.1365-2249.1992.tb03069.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/253\/42213176\/j.1365-2249.1992.tb03069.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:16:22Z","timestamp":1685700982000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/88\/2\/253\/6488195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb03069.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,5]]},"published":{"date-parts":[[1992,5]]}}}